XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
128 hedge funds and large institutions have $766M invested in Acceleron Pharma in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 65 increasing their positions, 28 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
37% less capital invested
Capital invested by funds: $1.21B → $766M (-$447M)
69% less call options, than puts
Call options by funds: $2.08M | Put options by funds: $6.71M
Holders
128
Holding in Top 10
3
Calls
$2.08M
Puts
$6.71M
Top Buyers
| 1 | +$20.5M | |
| 2 | +$17.8M | |
| 3 | +$15.1M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$13.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.88M |
Top Sellers
| 1 | -$17.9M | |
| 2 | -$5.63M | |
| 3 | -$4.3M | |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$3.69M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.93M |